Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease.
Mertens J, Weyler J, Dirinck E, Vonghia L, Kwanten WJ, Van Gaal LF, De Winter BY, Francque S, De Block C.
Cardiovasc Diabetol. 2025 May 29;24(1):230. doi: 10.1186/s12933-025-02764-y.
PMID:40442720
Cerebral small-vessel disease is associated with the severity of diabetic retinopathy in type 1 diabetes.